JPRN-UMIN000046397
Completed
未知
A dose finding study on the effect of continuous intake of test foods on the cognitive function. -a randomized, double-blind, parallel-group comparison trial- - A dose finding study on the effect of continuous intake of test foods on the cognitive function. -a randomized, double-blind, parallel-group comparison trial
IMEQRD Co., Ltd0 sites60 target enrollmentDecember 19, 2021
ConditionsHealthy adults
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Healthy adults
- Sponsor
- IMEQRD Co., Ltd
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Those who are receiving any types of medicines and/or Chinese medical treatment. 2\. Those who are managed by medical doctors for diet/exercise therapy. 3\. Those who have severe diseases or a history of severe diseases. 4\. Those who have strabismus, cataracta, or have surgical history of eye within 1year ago from the date of consent. 5\. Those who have currently been taking commercially available drugs, quasi\-drug products, and foods or supplements with functional claims. 6\. Those who have a drug/food allergy. 7\. Those whose MMSE\-J score are less than 24, or over 29\. 8\. Those who drink more than 60 g alcohol/day. 9\. Those who have excessive smoking habits (21 or more cigarettes / day) 10\. Those who are planning extremely change their lifestyle during the trial. 11\. Those who are planning travel to foreign countries during the trial. 12\. Those who joined other clinical trials from 1 month before this trial, or those who have currently been joined or planning to join other clinical trials. 13\. Those who are unsuitable for this trial, that judged by the principal investigator.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Beta-Blocker Therapy in Moderate to Severe COPDEUCTR2011-006008-11-GBTayside Clinical Trials Unit, University of Dundee45
Completed
Not Applicable
A study to evaluate the dose-response effect of tolvaptan 7.5mg or 15mg in HF patients who undergo cartdiac angiographyHeart FailureJPRN-UMIN000009924Showa University Northern Hospital100
Completed
Not Applicable
A dose response study of the effects of increased fruit and vegetables intake on vascular functioISRCTN50011192Food Standards Agency (UK)48
Terminated
Phase 2
To identify the effective dose(s) of RT234 (vardenafil inhalation powder) to acutely improve pulmonary vascular haemodynamics in study participants with Pulmonary Arterial Hypertension (PAH).Pulmonary Arterial HypertensionCardiovascular - Other cardiovascular diseasesACTRN12619001178134Respira Therapeutics Australia Pty Ltd14
Completed
Not Applicable
A confirmatory study on the effect of continuous intake of test food on bone metabolism. -A placebo-controlled, randomized, double-blind clinical trialJPRN-UMIN000046979IMEQRD Co., Ltd40